Tekla Research Development from 2010 to 2026
| HQH Stock | USD 19.89 0.30 1.53% |
Research Development | First Reported 2010-12-31 | Previous Quarter 0.5 | Current Value 0.48 | Quarterly Volatility 0.68518675 |
Check Tekla Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 188.3 K, Interest Expense of 0.0 or Selling General Administrative of 1.3 M, as well as many indicators such as Price To Sales Ratio of 174, Dividend Yield of 0.0762 or PTB Ratio of 1.0. Tekla financial statements analysis is a perfect complement when working with Tekla Healthcare Valuation or Volatility modules.
Tekla | Research Development | Build AI portfolio with Tekla Stock |
The Research Development trend for Tekla Healthcare Investors offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Tekla Healthcare is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Tekla Healthcare's Research Development Growth Pattern
Below is the plot of the Research Development of Tekla Healthcare Investors over the last few years. It is Tekla Healthcare's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tekla Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Tekla Research Development Regression Statistics
| Arithmetic Mean | 1.46 | |
| Geometric Mean | 1.27 | |
| Coefficient Of Variation | 46.91 | |
| Mean Deviation | 0.55 | |
| Median | 1.69 | |
| Standard Deviation | 0.69 | |
| Sample Variance | 0.47 | |
| Range | 2.14 | |
| R-Value | (0.56) | |
| Mean Square Error | 0.34 | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | (0.08) | |
| Total Sum of Squares | 7.51 |
Tekla Research Development History
About Tekla Healthcare Financial Statements
Investors use fundamental indicators, such as Tekla Healthcare's Research Development, to determine how well the company is positioned to perform in the future. Although Tekla Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Research Development | 0.50 | 0.48 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Tekla Healthcare Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is there potential for Asset Management & Custody Banks market expansion? Will Tekla introduce new products? Factors like these will boost the valuation of Tekla Healthcare. Market participants price Tekla higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.911 | Dividend Share 2.24 | Earnings Share 1.61 | Revenue Per Share | Quarterly Revenue Growth (0.49) |
Tekla Healthcare Inv's market price often diverges from its book value, the accounting figure shown on Tekla's balance sheet. Smart investors calculate Tekla Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Tekla Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.